|1.||Flores, Hilario: 1 article (12/2010)|
|2.||Morrison, Brittany A: 1 article (12/2010)|
|3.||Alaez, Carmen: 1 article (12/2010)|
|4.||Gorodezky, Clara: 1 article (12/2010)|
|5.||Dorak, M Tevfik: 1 article (12/2010)|
|6.||Ucisik-Akkaya, Esma: 1 article (12/2010)|
|7.||Okcu, Nihat: 1 article (04/2010)|
|8.||Tekin, Salim B: 1 article (04/2010)|
|9.||Bilici, Mehmet: 1 article (04/2010)|
|10.||Pirim, Ibrahim: 1 article (04/2010)|
|1.||Stomach Neoplasms (Stomach Cancer)
04/01/2010 - "It is probable that HLA-Cw5 is a risk factor for gastric cancer whereas HLA-DRB1*15 plays a protective role for this disease. "
04/01/2010 - "The study revealed that the HLA-Cw5 antigen is more prevalent in patients with gastric cancer (p=0.042) and that the HLA-DRB1*15 antigen is more prevelent in the control group (p=0.021). "
|2.||Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/01/2010 - "We noted a female-specific risk association in childhood ALL (pooled odds ratio (OR) = 2.6, 95% confidence interval (CI) = 1.5-4.5, Mantel-Haenszel P = 0.0009) similar to the stronger association of DRB1*1501 in females with MS. Examination of an HLA-C 5' flanking region SNP rs9264942, known to correlate with HLA-C expression, showed a protective association in girls (OR = 0.4, 95% CI = 0.2-0.7, Mantel-Haenszel P = 0.0003) similar to the protective HLA-Cw*05 association in MS. In a reference cell line panel, HLA-Cw5 homozygous samples (n = 8) were also homozygous for the minor allele of the SNP. "
|3.||Hepatitis A (Hepatitis, Infectious)
|4.||Crohn Disease (Crohn's Disease)
|5.||Transitional Cell Carcinoma
|3.||HLA-C Antigens (HLA-C)
|5.||HLA-DRB1 antigen (HLA DRB1)